Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Continuous dopaminergic stimulation, pulsatile dopaminergic stimulation].

A Destée1, R Bordet

  • 1Clinique Neurologique, EA 2683 MENRT, Service de Pharmacologie clinique, EA 1046 MNERT, CHU Lille.

Revue Neurologique
|April 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional connectivity and cognitive changes after donepezil treatment in healthy participants.

Psychopharmacology·2021
Same author

Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration.

Revue neurologique·2021
Same author

Brain-liver axis: a new pathway for cognitive disorders related to hepatic fibrosis.

European journal of neurology·2020
Same author

[Changes in blood pressure after introduction of an antidepressant in a public institution of mental health].

Annales de cardiologie et d'angeiologie·2020
Same author

Shift in Hospitalizations for Alzheimer's Disease to Related Dementias in France between 2007 and 2017.

The journal of prevention of Alzheimer's disease·2019
Same author

Factors Associated with Alzheimer's Disease: An Overview of Reviews.

The journal of prevention of Alzheimer's disease·2019

Levodopa is the gold standard for Parkinson's disease, but motor complications like dyskinesia are common. Stable, physiological dopaminergic stimulation is key to improving treatment outcomes.

Area of Science:

  • Neurology
  • Pharmacology

Context:

  • Parkinson's disease (PD) management relies on Levodopa.
  • Levodopa's efficacy is limited by motor complications, including motor fluctuations and dyskinesia.
  • These complications are more pronounced in younger PD patients.

Purpose:

  • To explore strategies for optimizing Levodopa therapy in Parkinson's disease.
  • To address the challenge of motor complications associated with Levodopa treatment.
  • To investigate methods for achieving more stable and physiological dopaminergic stimulation.

Summary:

  • Pulsed dopaminergic stimulation is implicated in the pathophysiology of Levodopa-induced motor complications.
  • Dopaminergic agonists represent a potential alternative therapeutic strategy.
  • Modulating Levodopa's peripheral pharmacokinetics with catechol-O-methyl transferase (COMT) inhibitors is another approach.

Related Experiment Videos

Impact:

  • Highlights the need for treatments that provide sustained dopaminergic stimulation.
  • Suggests alternative therapeutic avenues beyond standard Levodopa administration.
  • Informs future research directions for managing Parkinson's disease motor symptoms.